Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange
Journal of Clinical Apheresis2014Vol. 30(1), pp. 46–49
Citations Over Time
Abstract
Thrombotic thrombocytopenic purpura (TTP) is a hematologic emergency characterized by microangiopathic hemolytic anemia and thrombocytopenia. Plasma exchange is the standard treatment. Treating TTP without plasma exchange is a challenge. Due to religious beliefs, Jehovah's Witnesses do not accept transfusions of blood products. We report a case of successful treatment of TTP in a Jehovah's Witness using plasma exchange with albumin replacement.
Related Papers
- → Role of therapeutic plasma exchange in snake bite associated thrombotic microangiopathy—A case report with review of literature(2019)22 cited
- → The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy‐proven renal thrombotic microangiopathy(2022)11 cited
- → Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature(2017)8 cited
- → Life-Threatening Microangiopathy or Vitamin Deficiency: A Case Report of the Clinical Manifestations of Pseudo-Thrombotic Microangiopathic Anemia(2021)3 cited
- → Drug-Induced Thrombotic Microangiopathy Resulting in ESRD(2020)